These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 31953522)
1. Recurrent KRAS mutations identified in papillary renal neoplasm with reverse polarity-a comparative study with papillary renal cell carcinoma. Kim SS; Cho YM; Kim GH; Kee KH; Kim HS; Kim KM; Kim JH; Choi C Mod Pathol; 2020 Apr; 33(4):690-699. PubMed ID: 31953522 [TBL] [Abstract][Full Text] [Related]
2. Morphological, immunohistochemical, and genomic analyses of papillary renal neoplasm with reverse polarity. Kiyozawa D; Kohashi K; Takamatsu D; Yamamoto T; Eto M; Iwasaki T; Motoshita J; Shimokama T; Kinjo M; Oshiro Y; Yonemasu H; Oda Y Hum Pathol; 2021 Jun; 112():48-58. PubMed ID: 33811832 [TBL] [Abstract][Full Text] [Related]
3. Papillary renal neoplasm with reverse polarity-a comparative study with CCPRCC, OPRCC, and PRCC1. Wang T; Ding X; Huang X; Ye J; Li H; Cao S; Gao Y; Ma X; Huang Q; Wang B Hum Pathol; 2022 Nov; 129():60-70. PubMed ID: 35977593 [TBL] [Abstract][Full Text] [Related]
4. Papillary renal neoplasm with reverse polarity: a clinicopathologic study of 43 cases with a focus on the expression of KRAS signaling pathway downstream effectors. Kim B; Lee S; Moon KC Hum Pathol; 2023 Dec; 142():1-6. PubMed ID: 37797754 [TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and molecular characterisation of papillary renal neoplasm with reverse polarity and its renal papillary adenoma analogue. Chang HY; Hang JF; Wu CY; Lin TP; Chung HJ; Chang YH; Pan CC Histopathology; 2021 Jun; 78(7):1019-1031. PubMed ID: 33351968 [TBL] [Abstract][Full Text] [Related]
6. Frequent KRAS mutations in oncocytic papillary renal neoplasm with inverted nuclei. Tong K; Zhu W; Fu H; Cao F; Wang S; Zhou W; Liu C; Chen D; Fan S; Hu Z Histopathology; 2020 Jun; 76(7):1070-1083. PubMed ID: 31997427 [TBL] [Abstract][Full Text] [Related]
7. Papillary renal neoplasm with reverse polarity: A clinicopathological and molecular genetic characterization of 16 cases with expanding the morphologic spectrum and further support for a novel entity. Shen M; Yin X; Bai Y; Zhang H; Ru G; He X; Teng X; Chen G; Zhao M Front Oncol; 2022; 12():930296. PubMed ID: 35936734 [TBL] [Abstract][Full Text] [Related]
8. Papillary renal neoplasm with reverse polarity with a favorable prognosis should be separated from papillary renal cell carcinoma. Liu Y; Zhang H; Li X; Wang S; Zhang Y; Zhang X; Xu T; Dong Y; Dong L; Zhou L; Yang X; Wang C Hum Pathol; 2022 Sep; 127():78-85. PubMed ID: 35724772 [TBL] [Abstract][Full Text] [Related]
9. Papillary Renal Neoplasm With Reverse Polarity Is Often Cystic: Report of 7 Cases and Review of 93 Cases in the Literature. Wei S; Kutikov A; Patchefsky AS; Flieder DB; Talarchek JN; Al-Saleem T; Dulaimi E; Uzzo RG; Testa JR; Pei J Am J Surg Pathol; 2022 Mar; 46(3):336-343. PubMed ID: 34352808 [TBL] [Abstract][Full Text] [Related]
10. Papillary Renal Neoplasm With Reverse Polarity: A Clinical, Pathologic, and Molecular Study of 8 Renal Tumors From a Single Institution. Nova-Camacho LM; Martin-Arruti M; Díaz IR; Panizo-Santos Á Arch Pathol Lab Med; 2023 Jun; 147(6):692-700. PubMed ID: 36170616 [TBL] [Abstract][Full Text] [Related]
11. Non-coding RNA and gene expression analyses of papillary renal neoplasm with reverse polarity (PRNRP) reveal distinct pathological mechanisms from other renal neoplasms. Nemours S; Armesto M; Arestín M; Manini C; Giustetto D; Sperga M; Pivovarcikova K; Pérez-Montiel D; Hes O; Michal M; López JI; Lawrie CH Pathology; 2024 Jun; 56(4):493-503. PubMed ID: 38413252 [TBL] [Abstract][Full Text] [Related]
12. Recurrent KRAS mutations in papillary renal neoplasm with reverse polarity. Al-Obaidy KI; Eble JN; Nassiri M; Cheng L; Eldomery MK; Williamson SR; Sakr WA; Gupta N; Hassan O; Idrees MT; Grignon DJ Mod Pathol; 2020 Jun; 33(6):1157-1164. PubMed ID: 31534204 [TBL] [Abstract][Full Text] [Related]
13. Papillary Renal Neoplasm With Reverse Polarity: A Morphologic, Immunohistochemical, and Molecular Study. Al-Obaidy KI; Eble JN; Cheng L; Williamson SR; Sakr WA; Gupta N; Idrees MT; Grignon DJ Am J Surg Pathol; 2019 Aug; 43(8):1099-1111. PubMed ID: 31135486 [TBL] [Abstract][Full Text] [Related]
14. [Papillary renal neoplasm with reverse polarity: a clinicopathological analysis]. Ji RH; Wang XT; Li R; Ye SB; Wang X; Ma HH; Lu ZF; Rao Q; Xia QY Zhonghua Bing Li Xue Za Zhi; 2022 Jan; 51(1):23-27. PubMed ID: 34979749 [No Abstract] [Full Text] [Related]
15. Oncocytic papillary renal cell carcinoma: A clinicopathological and genetic analysis and indolent clinical course in 14 cases. Han G; Yu W; Chu J; Liu Y; Jiang Y; Li Y; Zhang W Pathol Res Pract; 2017 Jan; 213(1):1-6. PubMed ID: 27931799 [TBL] [Abstract][Full Text] [Related]
16. Oncocytic papillary renal cell carcinoma: a clinicopathological study emphasizing distinct morphology, extended immunohistochemical profile and cytogenetic features. Xia QY; Rao Q; Shen Q; Shi SS; Li L; Liu B; Zhang J; Wang YF; Shi QL; Wang JD; Ma HH; Lu ZF; Yu B; Zhang RS; Zhou XJ Int J Clin Exp Pathol; 2013; 6(7):1392-9. PubMed ID: 23826421 [TBL] [Abstract][Full Text] [Related]
17. Recurrent KRAS mutations are early events in the development of papillary renal neoplasm with reverse polarity. Al-Obaidy KI; Saleeb RM; Trpkov K; Williamson SR; Sangoi AR; Nassiri M; Hes O; Montironi R; Cimadamore A; Acosta AM; Alruwaii ZI; Alkashash A; Hassan O; Gupta N; Osunkoya AO; Sen JD; Baldrige LA; Sakr WA; Idrees MT; Eble JN; Grignon DJ; Cheng L Mod Pathol; 2022 Sep; 35(9):1279-1286. PubMed ID: 35152262 [TBL] [Abstract][Full Text] [Related]
18. Unilateral synchronous papillary renal neoplasm with reverse polarity and clear cell renal cell carcinoma: a case report with KRAS and PIK3CA mutations. Lee HJ; Shin DH; Park JY; Kim SY; Hwang CS; Lee JH; Kim JY; Sol MY; Nam JK Diagn Pathol; 2020 Oct; 15(1):123. PubMed ID: 33023600 [TBL] [Abstract][Full Text] [Related]
19. Papillary renal cell carcinoma: a clinicopathological and whole-genome exon sequencing study. Liu K; Ren Y; Pang L; Qi Y; Jia W; Tao L; Hu Z; Zhao J; Zhang H; Li L; Yue H; Han J; Liang W; Hu J; Zou H; Yuan X; Li F Int J Clin Exp Pathol; 2015; 8(7):8311-35. PubMed ID: 26339402 [TBL] [Abstract][Full Text] [Related]
20. Papillary renal neoplasm with reverse polarity may be a novel renal cell tumor entity with low malignant potential. Yang T; Kang E; Zhang L; Zhuang J; Li Y; Jiang Y; Wang H; Yu W; Zhang W Diagn Pathol; 2022 Aug; 17(1):66. PubMed ID: 36002896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]